BioCentury
ARTICLE | Company News

Teva management update

May 14, 2012 7:00 AM UTC

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA), Petah Tikva, Israel Business: Autoimmune, Neurology, Biosimilars Hired: Michael Hayden as CSO and president of global R&D, currently professor of med...